Bimagrumab · el anticuerpo anti-ActRII contra la pérdida de músculo · qué es y qué mostró BELIEVE
bimagrumab.com.mx
LaunchIndex first observed Bimagrumab · el anticuerpo anti-ActRII contra la pérdida de músculo · qué es y qué mostró BELIEVE (bimagrumab.com.mx) live on 11 November 2026. View its launch screenshot, category, and verification evidence.
A launch record built from evidence.
Bimagrumab · el anticuerpo anti-ActRII contra la pérdida de músculo · qué es y qué mostró BELIEVE (bimagrumab.com.mx) was first observed live on 11 November 2026.
Spanish-language health information site describing bimagrumab, an ActRII-targeting antibody, its mechanism, and trial results (BELIEVE), status, and history of the program. Informational, not for sale.
Its profile is classified as Media within Health / Health and wellness.
What the launch signal contained.
- First observed live
- Previous state
- No prior non-live observation
- Last verified
- Canonical host
- bimagrumab.com.mx
- Category
- Health / Health and wellness
- Website type
- Media
- Observed title
- Bimagrumab · el anticuerpo anti-ActRII contra la pérdida de músculo · qué es y qué mostró BELIEVE
- Observed description
- Qué es el bimagrumab: un anticuerpo que bloquea los receptores de activina tipo II para perder grasa sin perder músculo. Mecanismo, las cifras del ensayo BELIEVE y el estado real del programa.
- Detected technologies
- None detected
- Screenshot captured
- Evidence source
- Browser observation · Local
- Evidence confidence
- 93%
- HTTP status
- 200
A canonical launch profile for bimagrumab.com.mx.
Share the profile directly or add the optional badge to the website. A badge is never required for inclusion, verification, or ranking.
Is this your website?
Claim this profile to add verified owner information.
What do you make of this launch?
Vote on the site and leave a short note for other people exploring the new web.
Report an issueFlag spam, illegal or harmful content, or inaccurate information.
Reports are private and reviewed by the moderation team. No sign-in is required, so this report will be anonymous.
Join the discussion
Sign in with Google to vote or comment.
Sign in to participateComments
0 commentsBe the first to leave a useful observation.